Morning Briefing
Summaries of health policy coverage from major news organizations
Pfizer Targets November To Apply For Vaccine Authorization For Kids Under 5
Pfizer and BioNTech plan to file for Food and Drug Administration (FDA) emergency authorization in November for their COVID-19 vaccine for children younger than 5, Pfizer Chief Financial Officer Frank D'Amelio said this week. Pfizer has previously said the company expects to file in early October for emergency use authorization in children ages 5 to 11. (Weixel, 9/15)
Pfizer expects to release clinical trial data on how well its Covid-19 vaccine works in 6-month to 5-year-old children as early as the end of October, CEO Albert Bourla said Tuesday. Covid vaccine data for kids between ages 5 and 11 will come much sooner, he said, potentially ready to be submitted to the Food and Drug Administration by the end of this month. (Lovelace Jr., 9/14)
Children ages 5-11 may be able to get the shot before Halloween —
Pfizer is planning to submit data to the Food and Drug Administration by the end of this month with hopes for a green light to start vaccinating kids 5 to 11 years old before Halloween. Health officers across the Bay Area are starting to prepare how distribution will work once the vaccine is authorized for emergency use. ... Susan Rojas works with San Francisco's COVID-19 taskforce. Her staff is already preparing to expand the Mission's 24th Street pop-up site to be able to vaccinate up to 500 children per day once Pfizer's vaccine is authorized. "We have a lot of families coming in trying to figure out if they can put their names on a waitlist," she said. (Sierra, 9/15)
